PROASSURANCE CORP 8-K

What Happened ProAssurance Corporation (PRA) filed an 8-K on June 2, 2026 reporting progress on its previously announced merger with The Doctors Company. Under the March 19, 2025 Merger Agreement, Jackson Acquisition Corporation (a Doctors Company subsidiary) will merge into ProAssurance, with ProAssurance surviving as a wholly owned subsidiary of The Doctors Company. The company says stockholders approved the transaction on June 24, 2025, and the FTC granted early termination of the HSR waiting period on July 2, 2025.

Key Details

• Merger Agreement signed: March 19, 2025.
• Stockholder approval: Special meeting held June 24, 2025.
• Antitrust clearance: FTC early termination granted July 2, 2025.
• Insurance regulator approvals received (final) from: Alabama, District of Columbia, Illinois, Missouri, Pennsylvania, Texas, Vermont.
• Other approvals: Lloyd’s of London approval for PRA Corporate Capital Ltd.; Cayman Islands Monetary Authority approvals for Inova Re and Eastern Re.
• Pending: Final review by California insurance regulators; timing uncertain.
• Company expectation: Continues to anticipate closing the transaction by June 30, 2026, subject to remaining customary closing conditions.
• Filing includes standard forward‑looking statement disclosures and lists risks that could delay or prevent closing.

Why It Matters This 8-K updates investors that the merger is progressing through required regulatory reviews and lists several final approvals obtained, which materially increases the likelihood of closing. The remaining California insurance regulator review is the primary outstanding condition; failure or delay there could push back or derail the transaction. If completed, ProAssurance will become a wholly owned subsidiary of The Doctors Company, which could affect ProAssurance’s stock, operations, and strategic direction — risks and uncertainties are noted in the filing’s forward‑looking statement disclosures.